The Pharmacokinetics of Firocoxib after Multiple Oral Doses to Neonatal Foals
The purpose of this study was to determine the safety and pharmacokinetic profile of firocoxib in healthy neonatal foals. Foals are more sensitive to the side effects of nonsteroidal anti-inflammatory drugs, (NSAIDs), particularly due to immature renal clearance mechanisms and ulcerogenic effects on...
Main Author: | Hovanessian, Natasha |
---|---|
Other Authors: | Veterinary Medical Sciences |
Format: | Others |
Language: | en_US |
Published: |
Virginia Tech
2017
|
Subjects: | |
Online Access: | http://hdl.handle.net/10919/76823 http://scholar.lib.vt.edu/theses/available/etd-07132012-145000/ |
Similar Items
-
The effectiveness of marine based fatty acid compound (PCSO-524) and firocoxib in the treatment of canine osteoarthritis
by: Monchanok Vijarnsorn, et al.
Published: (2019-10-01) -
Cutaneous adverse drug reaction in a dog following firocoxib treatment
by: Migyeong Geum, et al.
Published: (2021-09-01) -
Evaluation of the foal survival score in a Danish‐Swedish population of neonatal foals upon hospital admission
by: Anna Bohlin, et al.
Published: (2019-05-01) -
Ethiopathogenesis, diagnostics and therapy of foal neonatal septicemia
by: Lauš Saša, et al.
Published: (2010-01-01) -
Assessment of the efficacy of firocoxib (Previcox®) and grapiprant (Galliprant®) in an induced model of acute arthritis in dogs
by: Andrea García de Salazar Alcalá, et al.
Published: (2019-08-01)